APA Citatie

Zhou, H., Liu, L., Shu, X., Wang, X., & Song, Y. (2019). Clinical Efficacy and Safety of High-Dose Dexamethasone Plus Low-Dose Rituximab as First-Line Therapy in Newly Diagnosed Primary Immune Thrombocytopenia. Indian J Hematol Blood Transfus.

Chicago Style citaat

Zhou, Hu, Liu Liu, Xinhui Shu, Xiaoran Wang, en Yongping Song. "Clinical Efficacy and Safety of High-Dose Dexamethasone Plus Low-Dose Rituximab As First-Line Therapy in Newly Diagnosed Primary Immune Thrombocytopenia." Indian J Hematol Blood Transfus 2019.

MLA citatie

Zhou, Hu, et al. "Clinical Efficacy and Safety of High-Dose Dexamethasone Plus Low-Dose Rituximab As First-Line Therapy in Newly Diagnosed Primary Immune Thrombocytopenia." Indian J Hematol Blood Transfus 2019.